









Markets
/
Stocks
/
nasdaq-bsgm
/

BioSig Technologies Inc

BSGM

6.100USD

0.000

Close 09/19, 16:00（ET）Quotes delayed by 15 min

187.84MMarket Cap

LossP/E TTM



BioSig Technologies Inc

6.100

0.000

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-10

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

103 / 208

Overall Ranking

242 / 4730

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 1 analysts

Buy

Current Rating

10.000

Target Price

+56.25%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.

Growing

The company is in a growing phase, with the latest annual income totaling USD 40.00K.

Undervalued

The company’s latest PE is -4.24, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 19.36M shares, increasing 4.63% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 990.15K shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-10

The company's current financial score is 6.48, which is lower than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 0.00, representing a year-over-year decrease of 100.00%, while its net profit experienced a year-over-year decrease of 20.44%.

Score

Industry at a Glance

Previous score

6.48

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.61

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.67

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.08

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.03

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-10

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is -4.56, which is -86.89% below the recent high of -0.60 and 61.24% above the recent low of -1.77.

Score

Industry at a Glance

Previous score

2.00

Change

-0.8

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 103/208

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-10

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for BioSig Technologies Inc is 10.00, with a high of 10.00 and a low of 10.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 1 analysts

Buy

Current Rating

10.000

Target Price

+42.86%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

BioSig Technologies Inc

BSGM

Intercontinental Exchange Inc

ICE

Cboe Global Markets Inc

CBOE

Nasdaq Inc

NDAQ

CME Group Inc

CME

Tradeweb Markets Inc

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-10

The company’s current price momentum score is 7.32, which is lower than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 5.74 and the support level at 3.72, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.34

Change

0.38

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.151

Neutral

RSI(14)

62.939

Neutral

STOCH(KDJ)(9,3,3)

64.865

Buy

ATR(14)

0.565

High Vlolatility

CCI(14)

132.236

Buy

Williams %R

0.866

Overbought

TRIX(12,20)

-0.280

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

4.590

Buy

MA10

4.666

Buy

MA20

4.863

Buy

MA50

5.241

Buy

MA100

4.802

Buy

MA200

2.927

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-10

The company’s current institutional recognition score is 5.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 55.79%, representing a quarter-over-quarter increase of 92.82%. The largest institutional shareholder is The Vanguard, holding a total of 990.15K shares, representing 2.81% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Garlikov (Donald E.)

2.30M

+39.29%

Amato (Anthony N.)

1.97M

+84.19%

The Vanguard Group, Inc.

Star Investors

59.26K

Armistice Capital LLC

854.95K

Hrkac (Frederick)

612.85K

-6.36%

Williams (Mitchell Young)

1.00M

Rossby Financial, LCC

451.13K

+61.62%

Risk Assessment

Currency: USD Updated: 2025-09-10

The company's beta value is 1.83. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.